tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

FEMY Stock Latest News

Femasys granted 180-day extension by Nasdaq to regain compliance
The FlyFemasys granted 180-day extension by Nasdaq to regain compliance
9h ago
FEMY
Femasys announces partnership with Refuah Health Center
PremiumThe Fly
Femasys announces partnership with Refuah Health Center
1d ago
FEMY
Femasys files to sell 68.42M shares of common stock for holders
PremiumThe Fly
Femasys files to sell 68.42M shares of common stock for holders
14d ago
FEMY
Femasys Launches At-the-Market Common Stock Offering
PremiumCompany Announcements
Femasys Launches At-the-Market Common Stock Offering
22d ago
8K
FEMY
Femasys Gains FDA Clearance for FemVue Diagnostic Device
PremiumCompany Announcements
Femasys Gains FDA Clearance for FemVue Diagnostic Device
27d ago
8K
FEMY
Femasys secures U.S. FDA clearance for FemVue Controlled device
PremiumThe FlyFemasys secures U.S. FDA clearance for FemVue Controlled device
27d ago
FEMY
PharmaCyte sells Femasys stake, sees cash position rising to $20M
Premium
The Fly
PharmaCyte sells Femasys stake, sees cash position rising to $20M
2M ago
FEMY
PMCB
Femasys initiated with a Buy at Laidlaw
Premium
The Fly
Femasys initiated with a Buy at Laidlaw
2M ago
FEMY
Femasys: Strategic Advancements and Financial Health Justify Buy Rating
PremiumRatings
Femasys: Strategic Advancements and Financial Health Justify Buy Rating
2M ago
FEMY
Femasys Secures Major Order for FemBloc Launch
PremiumCompany Announcements
Femasys Secures Major Order for FemBloc Launch
2M ago
8K
FEMY
Femasys advances global growth with second partner order for FemBloc in Europe
PremiumThe Fly
Femasys advances global growth with second partner order for FemBloc in Europe
2M ago
FEMY
Femasys Secures $12 Million Through Private Placement
PremiumCompany Announcements
Femasys Secures $12 Million Through Private Placement
2M ago
8K
FEMY
Femasys Receives FDA Approval for FemBloc Trial
PremiumCompany AnnouncementsFemasys Receives FDA Approval for FemBloc Trial
2M ago
8K
FEMY
Femasys secures FDA approval to advance final FemBloc trial phase
Premium
The Fly
Femasys secures FDA approval to advance final FemBloc trial phase
2M ago
FEMY
Femasys, Inc. Advances Non-Surgical Birth Control with FemBloc Study
Premium
Company Announcements
Femasys, Inc. Advances Non-Surgical Birth Control with FemBloc Study
3M ago
FEMY
Femasys announces initiation of post-market surveillance study for FemBloc
PremiumThe Fly
Femasys announces initiation of post-market surveillance study for FemBloc
3M ago
FEMY
Femasys Meets Nasdaq Equity Requirement After Offering
PremiumCompany Announcements
Femasys Meets Nasdaq Equity Requirement After Offering
3M ago
8K
FEMY
Femasys COO Daniel Currie Announces Retirement
PremiumCompany Announcements
Femasys COO Daniel Currie Announces Retirement
3M ago
8K
FEMY
Femasys jumps with Trump expected to expand IVF access
PremiumThe Fly
Femasys jumps with Trump expected to expand IVF access
3M ago
FEMY
VTI ETF News, 10/3/2025
PremiumMarket NewsVTI ETF News, 10/3/2025
3M ago
LVO
VTI
Strategic Partnership with Kebomed Boosts Femasys’ European Expansion for FemBloc
Premium
Ratings
Strategic Partnership with Kebomed Boosts Femasys’ European Expansion for FemBloc
4M ago
FEMY
Femasys announces partnership with Kebomend to commercialize FemBloc
Premium
The Fly
Femasys announces partnership with Kebomend to commercialize FemBloc
4M ago
FEMY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >